Is the Duration of Adjuvant Trastuzumab Debate Still Clinically Relevant?
The Lancet - United Kingdom
doi 10.1016/s0140-6736(19)30946-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2019
Authors
Publisher
Elsevier BV
Available in full text
June 1, 2019
Elsevier BV